Your browser doesn't support javascript.
loading
Correlates of SGLT-2-inhibitiors use among patients with atherosclerotic cardiovascular disease and type 2 diabetes mellitus: Insights from the department of veterans affairs.
Al Rifai, Mahmoud; Mahtta, Dhruv; Ramsey, David J; Lee, Michelle T; Krittanawong, Chayakrit; Navaneethan, Sankar D; Gregg, L Parker; Petersen, Laura A; Virani, Salim S.
Afiliación
  • Al Rifai M; Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, TX.
  • Mahtta D; Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, TX; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX.
  • Ramsey DJ; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX.
  • Lee MT; Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, TX; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX.
  • Krittanawong C; Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, TX.
  • Navaneethan SD; Section of Nephrology and Institute of Clinical and Translational Research, Baylor College of Medicine, and Michael E. DeBakey VA Medical Center, Houston, TX.
  • Gregg LP; Department of Medicine,Section of Nephrology, Baylor College of Medicine, Houston, TX.
  • Petersen LA; Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, TX; Section of Health Services Research, Baylor College of Medicine, Houston, TX.
  • Virani SS; Department of Medicine, Section of Cardiology, Baylor College of Medicine, Houston, TX; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations in Quality, Effectiveness, and Safety, Houston, TX; Departm
Am Heart J ; 248: 160-162, 2022 06.
Article en En | MEDLINE | ID: mdl-34968441
ABSTRACT
This study using data from the Veterans Affairs (VA) administrative and clinical dataset examined determinants of sodium-glucose cotransporter-2 inhibitors (SGLT-2i) use among patients with concomitant atherosclerotic cardiovascular disease (ASCVD) and diabetes mellitus. The aim of the present analysis was to identify barriers and facilitators associated with SGLT-2i in a real-world contemporary patient population in order to improve utilization of these guideline-directed agents.
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Veteranos / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Aterosclerosis / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Veteranos / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Aterosclerosis / Inhibidores del Cotransportador de Sodio-Glucosa 2 Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article